An Autotaxin/Lysophosphatidic Acid/Interleukin-6 Amplification Loop Drives Scleroderma Fibrosis-Reference-Cited by-同舟云学术

An Autotaxin/Lysophosphatidic Acid/Interleukin-6 Amplification Loop Drives Scleroderma Fibrosis

Published:2016-11-28 Issue:12 Volume:68 Page:2964-2974
ISSN:2326-5191
Container-title:Arthritis & Rheumatology
language:en
Short-container-title:Arthritis & Rheumatology

Author:

Castelino Flavia V.¹,Bain Gretchen²,Pace Veronica A.¹,Black Katharine E.¹,George Leaya¹,Probst Clemens K.¹,Goulet Lance²,Lafyatis Robert³,Tager Andrew M.¹

Affiliation:

1. Massachusetts General Hospital and Harvard Medical School; Boston Massachusetts

2. PharmAkea; San Diego California

3. Boston University; Boston Massachusetts

Funder

NIH

Scleroderma Foundation

Scleroderma Research Foundation grant

Publisher

Wiley

Subject

Immunology,Rheumatology,Immunology and Allergy

Reference43 articles.

1. Amelioration of dermal fibrosis by genetic deletion or pharmacologic antagonism of lysophosphatidic acid receptor 1 in a mouse model of scleroderma;Castelino;Arthritis Rheum,2011

2. Production of lysophosphatidic acid in blister fluid: involvement of a lysophospholipase D activity;Mazereeuw-Hautier;J Invest Dermatol,2005

3. Elevated serum levels of arachidonoyl-lysophosphatidic acid and sphingosine 1-phosphate in systemic sclerosis;Tokumura;Int J Med Sci,2009

4. Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis;Clements;J Rheumatol,1995

5. The value of the Health Assessment Questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time;Steen;Arthritis Rheum,1997

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Involvement of lysophosphatidic acid-LPA1-YAP signaling in healthy and pathological FAPs migration;Matrix Biology;2024-11

2. The Effect of Ionizing Irradiation on the Autotaxin-Lysophasphatidic Acid Axis and Interleukin-6/8 Secretion in Different Breast Cancer Cell Lines;Journal of Personalized Medicine;2024-09-12

3. Prediction of Disease Progression and Clinical Response in Systemic Sclerosis: Experience From a Proof‐of‐Concept Trial;ACR Open Rheumatology;2024-06-23

4. Identification of two novel chemical classes of Autotaxin (ATX) inhibitors using Enalos Asclepios KNIME nodes;Bioorganic & Medicinal Chemistry Letters;2024-05

5. Lysophosphatidic acid receptor 1 inhibition: a potential treatment target for pulmonary fibrosis;European Respiratory Review;2024-04-30